High Quality And Competitive Price Bodybuilding Releasing Polypeptide Hormones Tesamorelin CAS 218949-48-5

Description:

Tesamorelin, also known by its brand name Egrifta, is a synthetic form of growth hormone-releasing hormone (GHRH). It is a peptide-based medication used to treat certain medical conditions related to growth hormone deficiency and body fat distribution.

The primary medical use of tesamorelin is for reducing excess abdominal fat in HIV-infected patients with lipodystrophy, a condition characterized by abnormal fat distribution in the body. Lipodystrophy is a common side effect of antiretroviral therapy used to manage HIV, and it can lead to changes in body fat distribution, resulting in the accumulation of fat in the abdominal region.

By mimicking the action of natural GHRH, tesamorelin stimulates the pituitary gland to release growth hormone. The increased levels of growth hormone can help reduce visceral adipose tissue, the fat stored around organs in the abdomen, leading to improvements in body fat distribution.

Tesamorelin is typically administered as a subcutaneous injection (under the skin) and requires a prescription from a healthcare provider. It is essential to follow the prescribed dosage and administration guidelines to ensure safety and effectiveness.

Applications:

Tesamorelin primarily stimulates the release of growth hormone from the pituitary gland. The main therapeutic use of tesamorelin is to reduce excess abdominal fat in HIV-infected patients with lipodystrophy. Lipodystrophy is a condition characterized by abnormal fat distribution in the body, and it can occur as a side effect of antiretroviral therapy used to manage HIV.

The excess accumulation of fat in the abdominal region can lead to various health complications and may increase the risk of cardiovascular disease and metabolic disorders. Tesamorelin helps address this issue by promoting the breakdown and reduction of visceral adipose tissue, the fat stored around organs in the abdomen.

By mimicking the action of natural growth hormone-releasing hormone (GHRH), tesamorelin stimulates the pituitary gland to release growth hormone. The increased levels of growth hormone can have several effects, including:

Reduction of abdominal fat: Tesamorelin primarily targets the visceral fat in the abdominal area, leading to a decrease in waist circumference and improvements in body fat distribution.

Improvement of lipid profile: Tesamorelin treatment has been associated with reductions in total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglyceride levels, potentially improving cardiovascular health.

Usage:

Tesamorelin is a stabilized analogue of the growth hormone-releasing factor (GRF) that induces growth hormone (GH) in a specific and physiological manner. To date, clinical studies suggest that Tesamorelin reduces visceral fat in HIV-infected patients with abdominal lipo-hypertrophy as well as reducing abdominal fat in all individuals studied.

Dosing Administration:

Follow the doctor's instructions to use tesamorelin. Check whether the label on the drug has an accurate dose description.

An extra patient leaflet available tesamorelin. If you have any questions about this information, please contact your pharmacist.

Telamolin is usually injected at your doctor's office, hospital or clinic. If you use tesamorelin at home, health care providers will teach you how to use it. Make sure you know how to use tesamorelin. Follow the procedure you are teaching when you use the dose. If you have any questions, please contact your health care provider.

Do not use tesamorelin if it contains particles, turbid or discoloration, or if the vial is broken or damaged.

Use a doctor to teach you the right technique. Into the depths of the skin, do not enter the vein or muscle.

Make sure that the injection site is rotated in the stomach area in the direction of each dose. Do not inject tesamorelin into scar tissue, bruises or abdomen buttons.

Before using it needs to mix texamolin. Follow the doctor to tell you the way to mix.

Do not prepare tesamorelin until you are ready to use it. Immediately after mixing, tazaarine is used to discard any unused drugs. Do not store the prepared dose for later use.

Keep the product and syringes and needles out of the reach of children and stay away from pets. Do not reuse needles, syringes, or other materials. Please ask your health care staff how to deal with these substances after use. Comply with all local regulations.

If you miss a tesamorelin, please use it as soon as possible. If your next dose is almost time, skip the missed dose and return to your regular dosing regimen. Do not use 2 doses at a time.

OUR ADWANTAGE: